Description
MONOCLONAL ANTIBODY DEVELOPMENT CORRECT PO NUMBER
Base award description: MONOCLONAL ANTIBODY DEVELOPMENT
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-06-09+$12,840= $12,840
- Mod P000012022-06-22+$0= $12,840
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-06-09 | +$12,840 | $12,840 | MONOCLONAL ANTIBODY DEVELOPMENT |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2022-06-22 | +$0 | $12,840 | MONOCLONAL ANTIBODY DEVELOPMENT CORRECT PO NUMBER |
Related awards · 6
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KVLBRRAQ6UX1)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24E22P0098 | RPO EAST (36C24E) · AN41 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH | $4,646 | FY2022 |
| VA24017P0165 | RPO EAST (36C24E) · AN11 · R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH) | $10,828 | FY2017 |
| VA26216P1989 | 262-NETWORK CONTRACT OFFICE 22 · B504 · SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL | $6,129 | FY2016 |
| VA25113P3102 | 506-ANN ARBOR · Q301 · MEDICAL- LABORATORY TESTING | $15,131 | FY2013 |
| VA26213P0988 | 262-NETWORK CONTRACT OFFICE 22 · 6505 · DRUGS AND BIOLOGICALS | $3,363 | FY2013 |
| VA506D10047 | 506-ANN ARBOR · 6515 · MED & SURGICAL INSTRUMENTS,EQ & SUP | $19,120 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24522P0545_3600_-NONE-_-NONE- · retrieved 2026-09-26.